IPFK2 inhibitors (Exelixis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIPFK2 inhibitors (Exelixis)
Drug Alias Name6-phosphofructo-2-kinase inhibitors (Exelixis)EXEL-1415EXEL-1752EXEL-2008EXEL-0302
ClassificationSmall molecules
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A